View Older Stories View More Recent Stories
-
AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology
-
Deerfield Foundation Awards $1.5 Million to Improve Health, Accelerate Innovation, and Promote Equity
-
Neomorph Announces Appointment of Dr. Klaus Wagner, M.D., Ph.D. as Chief Medical Officer
-
Cohere Health Achieves Significant Growth in 2024, Accelerating Momentum as the Leader in AI-Driven Clinical Intelligence
-
Nema Health Raises $14.5 Million Series A to Expand Virtual PTSD Treatment Model and Promote Long-Term Healing
-
MMI to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Endologix Announces Leadership Transition
-
CURE® AND DEERFIELD MANAGEMENT OPEN 2025 XSEED AWARD APPLICATIONS
-
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Singular Genomics Systems, Inc. Buyout
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Singular Genomics Systems, Inc. (Nasdaq - OMIC), Nordstrom, Inc. (NYSE - JWN), Despegar.com, Corp. (NYSE - DESP
-
Singular Genomics Systems (OMIC) Acquired by Deerfield for $20/sh Cash
-
Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share
-
Pleno, Inc. Appoints Dr. Vik Vaz, M.D. as Chief Executive Officer & President to Drive Commercial Growth After Closing $25M Series B Funding
-
InCarda Therapeutics Appoints Dr. Myles Greenberg as New CEO
-
CORRECTING and REPLACING InCarda Therapeutics Appoints Dr. Myles Greenberg as New CEO
-
Presidio Medical™ Announces Appointment of Richard J. Buchholz to Join its Board of Directors
-
CURE® SURVEY UNVEILS WHAT INVESTORS LOOK FOR IN FUNDING WOMEN'S HEALTH
-
Form 13F-HR DEERFIELD MANAGEMENT For: Sep 30
-
Adela to Present Biological Insights into its Tissue-Agnostic Assay for Molecular Residual Disease Detection at the AACR Special Conference in Cancer Research
-
Form 4 ARS Pharmaceuticals, For: Nov 11 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates
-
Endologix Announces 36-Month Results of DETOUR2 Study at 2024 VIVA Late-Breaking Clinical Trial Session
-
Lomond Therapeutics Completes Reverse Merger and Closes $44 Million Private Placement
-
Aileron Therapeutics (ALRN) and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma
-
Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma
-
Aerovate Therapeutics (AVTE) and Jade Biosciences Announce Merger Agreement
-
Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement
-
MMI’s Symani® Surgical System Named a TIME Best Invention of 2024
-
Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases
-
Petfolk Receives Series C Investment Led by Deerfield Management to Advance the Evolution of Veterinary Care
-
Global Health Exhibition Opens its Doors Tomorrow to Record-Breaking 100,000+ Attendees to World's Premier Healthcare Transformation Event
-
Cohere Health Names Finance Industry Veteran Robert Shepardson as New Chief Financial Officer
-
Cohere Health and MCG Partner to Deliver Best-in-Class Prior Authorization Solution
-
Deerfield Management and the University of North Carolina Eshelman School of Pharmacy Launch Biotherapeutics Certificate Program Bridging Academia and Industry
-
UAE BioTech Symposium Announces Abu Dhabi and Dubai, UAE Program
-
Brookdale Senior Living (BKD) to acquire 41 currently leased communities
-
Brookdale Senior Living to acquire 41 currently leased communities
-
Pairwise Poised to Revolutionize Agriculture with Industry-Leading Fulcrum™ Platform following $40M Series C Funding
-
Adela Announces Clinical Validation Results for Head & Neck Cancer MRD Test Simultaneously Published in Annals of Oncology and Presented at ESMO 2024
-
Form 3 Bicara Therapeutics Inc. For: Sep 12 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Singular Genomics Systems (OMIC) Receives Non-Binding Acquisition Proposal from Deerfield
-
Singular Genomics Receives Non-Binding Acquisition Proposal from Deerfield
-
Singular Genomics Systems (OMIC) receives takeover proposal from Deerfield
-
SpectraWAVE Announces $50M Series B Financing to Drive Commercial Expansion and Product Additions to the HyperVue™ Imaging System
-
Cure® Announces 2024 XSeed Award Winners, Promoting Women- and Minority-Led Life Science Startups in New York City
-
CobiCure Launches Fellowship Program to Bridge Gaps in Pediatric MedTech Innovation
-
Vesta Healthcare Raises $65 Million in Financing to Propel Growth
-
Horizon Technology Finance (HRZN) Provides $35 Million Venture Loan Facility to Vesta Healthcare
-
Endologix to Present at 22nd Annual Global Morgan Stanley Conference
-
Horizon Technology Finance Provides $35 Million Venture Loan Facility to Vesta Healthcare
